Article Details

Emergent BioSolutions and Rocketvax Announce Investment Agreement - Contract Pharma

Retrieved on: 2025-03-12 21:53:44

Tags for this article:

Click the tags to see associated articles and topics

Emergent BioSolutions and Rocketvax Announce Investment Agreement - Contract Pharma. View article details on hiswai:

Summary

The article relates to the key concept of 'COVID' through a strategic partnership between Emergent BioSolutions and Rocketvax to develop a next-generation viral vaccine, including a live-attenuated COVID-19 vaccine, highlighting virology and vaccine research. Tags encompass key players and areas of focus, such as Emergent, vaccine development, and collaboration with the NIH.

Article found on: www.contractpharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up